vimarsana.com

Page 46 - ஜப்பான் அமைச்சகம் ஆஃப் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Japan s handling of COVID-19 lacks transparency

Feb 12, 2021 Several weeks ago, Hiroto (a pseudonym) received a phone call from a friend. The friend, who had met Hiroto for dinner a few days prior, plainly stated on the phone call that he had tested positive for COVID-19 recently and urged everyone he had met within a week to also get tested. Alarmed, Hiroto immediately began phoning clinics near his house to see if he could schedule a COVID-19 test as soon as possible. Hiroto’s situation is becoming more common, as Japan’s COVID-19 data shows the number of new infections in the country jumping by more than 1,000 every day for the past several weeks. However, with slightly less than 400,000 cumulative cases and less than 6,000 deaths, Japan’s situation seems much better than those of Western countries. Cultural advantages, including the widespread use of masks and adherence to social distancing guidelines, may have suppressed COVID-19 infections and allowed daily lives to continue without the need for strict lockd

Experts urge caution as coronavirus variants spread in Japan

Experts urge caution as coronavirus variants spread in Japan February 11, 2021 (Mainichi Japan) Doctor Anil Mehta and Apprentice Nursing Associate Ellie Bull prepare syringes with doses of the AstraZeneca vaccine at the Welcome Centre in Ilford, east London, on Friday, Feb. 5, 2021. (AP Photo/Frank Augstein) TOKYO The number of people found infected with new strains of the coronavirus in Japan has topped 100, with community infections reported and major clusters seen in Saitama Prefecture, north of Tokyo. The World Health Organization (WHO) said that one variant was up to 70% more transmissible than the original, and experts in Japan are calling for people to be careful.

Takeda Submits New Drug Application to Manufacture and Market Darvadstrocel In Japan for Treatment of Complex Perianal Fistulas in Adult Patients with Crohn s Disease

Takeda Pharmaceutical Company Limited Takeda Submits New Drug Application to Manufacture and Market Darvadstrocel In Japan for Treatment of Complex Perianal Fistulas in Adult Patients with Crohn s Disease Wednesday, February 10, 2021 12:15PM IST (6:45AM GMT)   Takeda Applies for Approval for the Company’s First Allogeneic Stem Cell Therapy in Japan If Approved, Darvadstrocel Would Offer a Potential Cell-Mediated Closure Option for Adult Patients in Japan Who Do Not Respond to Conventional or Biologic Therapies for Complex Perianal Fistulas in Crohn’s Disease 1,2 Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has submitted an application to the Japanese Ministry of Health, Labour and Welfare to manufacture and market darvadstrocel (development code: Cx601) for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease (CD).

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.